ABSTRACT
BACKGROUND: Contaminated handwashing sinks have been identified as reservoirs that can facilitate colonization/infection of patients with multidrug-resistant (MDR) Gram-negative bacteria (GNB) in intensive care units (ICUs). AIM: To assess the impact of removing patients' sinks and implementing other water-safe strategies on the annual rates of ICU-acquired MDR-GNB. METHODS: This six-year quasi-experimental study was conducted from January 2011 to December 2016. The intervention was carried out in August 2014 in two adult ICU wards with 12 rooms each. To assess the changes in annual MDR-GNB rates before and after the intervention, we used segmented regression analysis of an interrupted time-series. Crude relative risk (RR) rates were also calculated. FINDINGS: The incidence rates of MDR-GNB were 9.15 and 2.20 per 1000 patient-days in the pre- and post-intervention periods, respectively. This yielded a crude RR of acquiring MDR-GNB of 0.24 (95% confidence interval: 0.17-0.34). A significant change in level was observed between the MDR-GNB rate at the first point of the post-intervention period and the rate predicted by the pre-intervention time trend. CONCLUSION: The implementation of a new water-safe policy, which included the removal of sinks from all patient rooms, successfully improved the control of MDR-GNB spread in an ICU with endemic infection. Our results support the contribution of sink use with the incidence of MDR-GNB in endemic environments.
Subject(s)
Cross Infection/prevention & control , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/prevention & control , Infection Control/methods , Water Supply , Cross Infection/epidemiology , Gram-Negative Bacterial Infections/epidemiology , Humans , Incidence , Intensive Care Units , Non-Randomized Controlled Trials as Topic , Patients' Rooms , Risk AssessmentABSTRACT
PURPOSE: To determine whether macrolide-based treatment is associated with mortality in critically ill H1N1 patients with primary viral pneumonia. METHODS: Secondary analysis of a prospective, observational, multicenter study conducted across 148 Intensive Care Units (ICU) in Spain. RESULTS: Primary viral pneumonia was present in 733 ICU patients with pandemic influenza A (H1N1) virus infection with severe respiratory failure. Macrolide-based treatment was administered to 190 (25.9 %) patients. Patients who received macrolides had chronic obstructive pulmonary disease more often, lower severity on admission (APACHE II score on ICU admission (13.1 ± 6.8 vs. 14.4 ± 7.4 points, p < 0.05), and multiple organ dysfunction syndrome less often (23.4 vs. 30.1 %, p < 0.05). Length of ICU stay in survivors was not significantly different in patients who received macrolides compared to patients who did not (10 (IQR 4-20) vs. 10 (IQR 5-20), p = 0.9). ICU mortality was 24.1 % (n = 177). Patients with macrolide-based treatment had lower ICU mortality in the univariate analysis (19.2 vs. 28.1 %, p = 0.02); however, a propensity score analysis showed no effect of macrolide-based treatment on ICU mortality (OR = 0.87; 95 % CI 0.55-1.37, p = 0.5). Moreover, the sensitivity analysis revealed very similar results (OR = 0.91; 95 % CI 0.58-1.44, p = 0.7). A separate analysis of patients under mechanical ventilation yielded similar results (OR = 0.77; 95 % CI 0.44-1.35, p = 0.4). CONCLUSION: Our results suggest that macrolide-based treatment was not associated with improved survival in critically ill H1N1 patients with primary viral pneumonia.
Subject(s)
Hospital Mortality , Influenza, Human/drug therapy , Macrolides/therapeutic use , Pneumonia, Viral/drug therapy , APACHE , Adult , Coinfection , Comorbidity , Female , Humans , Influenza A Virus, H1N1 Subtype , Influenza, Human/mortality , Influenza, Human/therapy , Intensive Care Units/statistics & numerical data , Length of Stay , Male , Middle Aged , Multicenter Studies as Topic , Pneumonia, Viral/mortality , Pneumonia, Viral/therapy , Propensity Score , Prospective Studies , Respiratory Insufficiency/drug therapy , Respiratory Insufficiency/etiology , Respiratory Insufficiency/mortality , Spain/epidemiology , Treatment OutcomeABSTRACT
Los virus tienen un papel importante dentro de las infecciones graves en los pacientes adultos, que en algunas ocasiones llegan a necesitar hospitalización e ingreso en unidades de cuidados intensivos, especialmente en casos de síndrome de distrés respiratorio del adulto y encefalitis. Las infecciones por virus influenza y parainfluenza, virus sincitial respiratorio, herpes virus y adenovirus son las que más frecuentemente causan estos cuadros. Se ha realizado una revisión de la literatura pormenorizada y actualizada de epidemiología, patogénesis, manifestaciones clínicas y aproximación terapéutica de las infecciones virales en pacientes inmunocompetentes. Por otro lado, si bien la neumonía asociada a ventilación mecánica tiene como etiología más frecuente las infecciones bacterianas, recientemente el papel de los virus como patógenos en estas infecciones está en debate, por lo que se hace una breve revisión de su papel etiopatogénico en la neumonía asociada a ventilación mecánica (AU)
Viruses play a significant role in serious infections in adults and sometimes leadto the need for hospitalization and admission to intensive care units, especially in cases ofsevere respiratory distress or encephalopathy. Influenza and parainfluenza viruses, syncytialrespiratory virus, herpes viruses and adenovirures are the most frequent causes of these severeinfections. A review of the literature has been performed in order to update the epidemiology,pathogenesis and therapeutic approach of viral infections affecting immunocompetent patients. Furthermore, ventilator-associated pneumonia (VAP) is the most frequent nosocomial infectionin intensive care units and has a high morbidity and mortality rate. It is mainly a bacterialdisease, although the potential role of viruses as pathogens or copathogens in VAP is underdiscussion. Therefore, a brief review of the potential pathogenic role of viruses in VAP has alsobeen performed (AU)
Subject(s)
Humans , Immunocompetence , Virus Diseases/immunology , Risk Factors , Acute Disease , PrognosisABSTRACT
Viruses play a significant role in serious infections in adults and sometimes lead to the need for hospitalization and admission to intensive care units, especially in cases of severe respiratory distress or encephalopathy. Influenza and parainfluenza viruses, syncytial respiratory virus, herpes viruses and adenovirures are the most frequent causes of these severe infections. A review of the literature has been performed in order to update the epidemiology, pathogenesis and therapeutic approach of viral infections affecting immunocompetent patients. Furthermore, ventilator-associated pneumonia (VAP) is the most frequent nosocomial infection in intensive care units and has a high morbidity and mortality rate. It is mainly a bacterial disease, although the potential role of viruses as pathogens or copathogens in VAP is under discussion. Therefore, a brief review of the potential pathogenic role of viruses in VAP has also been performed.
Subject(s)
Immunocompetence , Virus Diseases , Acute Disease , Adult , Antiviral Agents/therapeutic use , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/virology , Humans , Meningitis, Aseptic/drug therapy , Meningitis, Aseptic/epidemiology , Meningitis, Aseptic/virology , Pneumonia, Ventilator-Associated/virology , Prognosis , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/virology , Risk Factors , Virus Diseases/diagnosis , Virus Diseases/drug therapy , Virus Diseases/epidemiology , Virus Diseases/therapy , Virus Diseases/virologyABSTRACT
ResumenSer receptor de un trasplante de órgano sólido, así como recibir tratamiento quimioterápico para una enfermedad hematólógica maligna, predispone claramente a padecer infecciones virales tanto comunes como oportunistas, de origen tanto comunitario como procedentes del donante de órganos y/o de una reactivación de un virus latente endógeno. Herpes virus y más especialmente citomegalovirus y virus de Epstein-Barr son los que con más frecuencia afectan a estos enfermos, así como los virus respiratorios. El tratamiento consiste en la combinación de reducir la inmunodepresión inducida junto con tratamiento antiviral. Se ha realizado una revisión de la literatura pormenorizada y actualizada de la epidemiología, la patogenia, las manifestaciones clínicas y la aproximación terapéutica de las infecciones virales en estos enfermos (AU)
Abstract Being a solid organ and hematopoietic stem cell transplant recipient as well as receivingchemotherapy for a malignant hematological disease clearly predispose the subject to avariety of viral infections, both common and opportunistic diseases. The patient may haveacquired these infections from the community as well as from the donor organ (donor-derivedinfections) and/or from reactivation of an endogenous latent virus. Herpes viruses and especiallythe cytomegalovirus and Epstein-Barr virus are among the most common of the opportunisticviral pathogens affecting these patients, in addition to respiratory viruses. Treatment consistsin antiviral drug therapies combined with the reduction in the degree of the induced immunosuppression.A review of the literature has been performed in order to update the epidemiology,pathogenesis, clinical manifestations and therapeutic approach of the viral infections in theseimmunocompromised patients (AU)
Subject(s)
Humans , Virus Diseases/immunology , Critical Illness , Cross Infection/virology , Immunocompromised Host , Opportunistic Infections/virology , Cross Infection/immunology , Opportunistic Infections/immunology , Risk FactorsABSTRACT
Being a solid organ and hematopoietic stem cell transplant recipient as well as receiving chemotherapy for a malignant hematological disease clearly predispose the subject to a variety of viral infections, both common and opportunistic diseases. The patient may have acquired these infections from the community as well as from the donor organ (donor-derived infections) and/or from reactivation of an endogenous latent virus. Herpes viruses and especially the cytomegalovirus and Epstein-Barr virus are among the most common of the opportunistic viral pathogens affecting these patients, in addition to respiratory viruses. Treatment consists in antiviral drug therapies combined with the reduction in the degree of the induced immunosuppression. A review of the literature has been performed in order to update the epidemiology, pathogenesis, clinical manifestations and therapeutic approach of the viral infections in these immunocompromised patients.
